IL2 and neoplasm: Similarly, a biodegradable nanoparticle platform delivering IL-2, anti-CD28, Pam3CSK4, and a NOD2 agonist, was shown to stimulate endogenous tumor-infiltrating T cells and slow tumor growth (32).